FIELD: medicine.
SUBSTANCE: present invention relates to immunology. Disclosed is a polypeptide construct capable of specifically binding tumour necrosis factor alpha (TNF-alpha) containing two or four antagonists of single-domain antibodies directed against TNF-alpha, and one single-domain antibody directed against whey protein. Besides, it contains composition and coding nucleic acid.
EFFECT: present invention can be used in therapy of disorders associated with inflammatory processes or autoimmune diseases.
12 cl, 18 dwg, 11 tbl, 9 ex
Authors
Dates
2019-10-24—Published
2012-03-05—Filed